TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04760431 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04872166 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04872166 — Predictive Biomarker (PRD): GATA3 mRNA
Genes: GATA3
Study NCT04872166 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04872166 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05283720 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05175547 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06482853 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05456191 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05456191 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT06140836 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06293794 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06353256 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06565104 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04137653 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study NCT05224505 — Predictive Biomarker (PRD): FKRP mRNA
Genes: FKRP
Study NCT04417166 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05016310 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06414746 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT05973773 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05973773 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05379517 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05706272 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT06025630 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04907097 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06559891 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06586268 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04735562 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study NCT06302933 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT06583109 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06583109 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05625087 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05625087 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT06604494 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06599697 — Predictive Biomarker (PRD): HMGCR mRNA
Genes: HMGCR
Study NCT06597734 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05842265 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study NCT06656364 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06347068 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT06646237 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06646237 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT06665737 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06589804 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06586515 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02645149 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06668584 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05218421 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06667414 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04782375 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05343689 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04825964 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06669247 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06669247 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT06669247 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05687266 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05687266 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05687266 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05958953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06635824 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06608901 — Predictive Biomarker (PRD): NPR1 mRNA
Genes: NPR1; ANPRA
Study NCT06608901 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06614738 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT06615609 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06079736 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00987818 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04981119 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06607185 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06676046 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06676046 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05117008 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04953104 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study NCT06591598 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06591598 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06615479 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT05987332 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06252649 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06479629 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05151640 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06682793 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06682793 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06685718 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05694364 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study NCT04982926 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04982926 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06692426 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT06692426 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06328777 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05410145 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04797104 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04797104 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06630650 — Predictive Biomarker (PRD): DOK7 mRNA
Genes: DOK7; C4orf25
Study NCT06630650 — Predictive Biomarker (PRD): COLQ mRNA
Genes: COLQ
Study NCT06630611 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06690281 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06690281 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06691256 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06696456 — Predictive Biomarker (PRD): OTOF mRNA
Genes: OTOF; FER1L2
Study NCT04309552 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT06701591 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04773782 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT04773782 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT06627192 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06492564 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06170229 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06320171 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06320171 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06695845 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06714006 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT06714071 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06521775 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06714357 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06714357 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05100628 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT06605963 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06607198 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06607198 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06607198 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06607198 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06607198 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06609668 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06729021 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06730126 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study NCT06672705 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06724575 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT06731478 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05629858 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05629858 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06733935 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06728462 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06745908 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT06745908 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06745908 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06745908 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06759272 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT06735144 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT06762275 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06762483 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06762223 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06761976 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06513650 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06764459 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05821933 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05602168 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT06194955 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT06768905 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06773975 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06773975 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06776341 — Predictive Biomarker (PRD): GEMIN5 mRNA
Genes: GEMIN5
Study NCT05504278 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06759844 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06777316 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT06777316 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT06056570 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05145361 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT05507879 — Predictive Biomarker (PRD): TRPC6 mRNA
Genes: TRPC6; TRP6
Study NCT05008484 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05321082 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05866484 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04911491 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05636618 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT05348577 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT06515470 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06515470 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06515470 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06515470 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05870917 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT05078866 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06172478 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT04273022 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT04273022 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT04273022 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04273022 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06341933 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06092333 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04507503 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT05550298 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05666310 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04956640 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06283459 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05916625 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT05916625 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05916625 — Safety Biomarker (SAF): BDNF
Study NCT06470568 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06470568 — Predictive Biomarker (PRD): CTSB mRNA
Genes: CTSB; CPSB
Study NCT04802759 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04802759 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04802759 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05781334 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06281665 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04101851 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06414148 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06474507 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT05892003 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT06110858 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04359784 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05569057 — Predictive Biomarker (PRD): TNFRSF1B mRNA
Genes: TNFRSF1B; TNFBR; TNFR2
Study NCT05569057 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06607289 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT04787744 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study NCT06608823 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06619587 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06749756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06760078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06762431 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06761482 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06761235 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06762405 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05251376 — Predictive Biomarker (PRD): LYN mRNA
Genes: LYN; JTK8
Study NCT06761053 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06365567 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00002303 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT05135195 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05979636 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05256342 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT04936529 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04796688 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05946538 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05513664 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05513664 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05178030 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05178030 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06140095 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04540289 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06255951 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04990752 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04990752 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05965856 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT05347992 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT05858944 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06537297 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06503328 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT06503328 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study NCT06503328 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT04601857 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT04601857 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05719506 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05719506 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04271436 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT06045091 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05641428 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05413135 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study NCT06608342 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06608342 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT06706076 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06706076 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06706076 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06761118 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06762262 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04695860 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT04695860 — Predictive Biomarker (PRD): PHEX mRNA
Genes: PHEX; PEX
Study NCT04788797 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05536089 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04677660 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06468527 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06055465 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06055465 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05422781 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT06148311 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03462212 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06385093 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06426368 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05408416 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06410625 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT04976218 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05785507 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05785507 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG